Valentina Vanni Selected Research

Cholinergic Agents (Cholinergics)

12/2021	Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia.
1/2018	Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentina Vanni Research Topics

Disease

4	Inflammation (Inflammations) 10/2022 - 01/2020
4	Multiple Sclerosis 11/2021 - 01/2020
3	Dystonia (Limb Dystonia) 12/2021 - 01/2018
3	Dystonia musculorum deformans type 1 12/2021 - 01/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 01/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2019
1	Mood Disorders (Mood Disorder) 10/2022
1	Disease Progression 01/2022
1	Necrosis 11/2021
1	Anhedonia 01/2020
1	Fatigue 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Movement Disorders (Movement Disorder) 01/2018
1	Neuroinflammatory Diseases 01/2018

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2020 - 01/2018
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2021 - 01/2018
2	Cholinergic Agents (Cholinergics)IBA 12/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	CuprizoneIBA 01/2019 - 01/2019
1	Interleukin-2 (IL2)IBA 10/2022
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 12/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021
1	ParvalbuminsIBA 11/2021
1	Biological ProductsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2019
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2019
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2018

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2019
1	Immunomodulation 10/2022
1	Transcranial Magnetic Stimulation 01/2022